Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes The TRIGR Randomized Clinical Trial

TRIGR Study Group; Mila Hyytinen; Mikael Knip; Hans K. Åkerblom; Eva Al Taji; Dorothy Becker; Jan Bruining; Luis Castano; Thomas Danne; Carine de Beaufort; Hans-Michael Dosch; John Dupre; William D. Fraser; Neville Howard; Jorma Ilonen; Daniel Konrad; Olga Kordonouri; Jeffrey P. Krischer; Margaret L. Lawson; Johnny Ludvigsson; Laszlo Madacsy; Jeffrey L. Mahon; Anne Ormisson; Jerry P. Palmer; Paolo Pozzilli; Erkki Savilahti; Manuel Serrano-Rios; Marco Songini; Shayne Taback; Outi Vaarala; Neil H. White; Suvi M. Virtanen; Renata Wasikowa; Maija Heikkilä; Minna  Hirvasniemi; Kristiina Luopajärvi; Susanne Elise Johansson; Päivi Kleemola; Anna Parkkola; Hanna-Mari Pigg; Hilkka Puttonen; Martin Renlund; Kirsi Salonen; Heli Suomalainen; Kari Teramo; Anna-Liisa Järvenpää; Anu-Maaria Hämäläinen

doi:10.1001/jama.2017.19826

Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes The TRIGR Randomized Clinical Trial

TRIGR Study Group, Mila Hyytinen, Mikael Knip, Hans K. Åkerblom, Eva Al Taji, Dorothy Becker, Jan Bruining, Luis Castano, Thomas Danne, Carine de Beaufort, Hans-Michael Dosch, John Dupre, William D. Fraser, Neville Howard, Jorma Ilonen, Daniel Konrad, Olga Kordonouri, Jeffrey P. Krischer, Margaret L. Lawson, Johnny LudvigssonLaszlo Madacsy, Jeffrey L. Mahon, Anne Ormisson, Jerry P. Palmer, Paolo Pozzilli, Erkki Savilahti, Manuel Serrano-Rios, Marco Songini, Shayne Taback, Outi Vaarala, Neil H. White, Suvi M. Virtanen, Renata Wasikowa, Maija Heikkilä, Minna Hirvasniemi, Kristiina Luopajärvi, Susanne Elise Johansson, Päivi Kleemola, Anna Parkkola, Hanna-Mari Pigg, Hilkka Puttonen, Martin Renlund, Kirsi Salonen, Heli Suomalainen, Kari Teramo, Anna-Liisa Järvenpää, Anu-Maaria Hämäläinen

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

Alkuperäiskieli	englanti
Lehti	JAMA : The Journal of the American Medical Association
Vuosikerta	319
Numero	1
Sivut	38-48
Sivumäärä	11
ISSN	0098-7484
DOI - pysyväislinkit	https://doi.org/10.1001/jama.2017.19826 https://doi.org/10.1001/jama.2017.19826
Tila	Julkaistu - 2 tammik. 2018
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä, vertaisarvioitu

Tieteenalat

3121 Yleislääketiede, sisätaudit ja muut kliiniset lääketieteet

Pääsy asiakirjaan

Siteeraa tätä

TRIGR Study Group, Hyytinen, M., Knip, M., Åkerblom, H. K., Al Taji, E., Becker, D., Bruining, J., Castano, L., Danne, T., de Beaufort, C., Dosch, H.-M., Dupre, J., Fraser, W. D., Howard, N., Ilonen, J., Konrad, D., Kordonouri, O., Krischer, J. P., Lawson, M. L., ... Hämäläinen, A.-M. (2018). Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes The TRIGR Randomized Clinical Trial. JAMA : The Journal of the American Medical Association, 319(1), 38-48. https://doi.org/10.1001/jama.2017.19826, https://doi.org/10.1001/jama.2017.19826

@article{806edd81c5bc465496696eb1e8bbad06,

title = "Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes The TRIGR Randomized Clinical Trial",

keywords = "BETA-CELL AUTOIMMUNITY, ISLET AUTOIMMUNITY, GENERAL-POPULATION, CHILDREN, CHILDHOOD, AUTOANTIBODIES, SUSCEPTIBILITY, PROGRESSION, MELLITUS, INSULIN, 3121 General medicine, internal medicine and other clinical medicine",

author = "{TRIGR Study Group} and Mila Hyytinen and Mikael Knip and {\AA}kerblom, {Hans K.} and {Al Taji}, Eva and Dorothy Becker and Jan Bruining and Luis Castano and Thomas Danne and {de Beaufort}, Carine and Hans-Michael Dosch and John Dupre and Fraser, {William D.} and Neville Howard and Jorma Ilonen and Daniel Konrad and Olga Kordonouri and Krischer, {Jeffrey P.} and Lawson, {Margaret L.} and Johnny Ludvigsson and Laszlo Madacsy and Mahon, {Jeffrey L.} and Anne Ormisson and Palmer, {Jerry P.} and Paolo Pozzilli and Erkki Savilahti and Manuel Serrano-Rios and Marco Songini and Shayne Taback and Outi Vaarala and White, {Neil H.} and Virtanen, {Suvi M.} and Renata Wasikowa and Maija Heikkil{\"a} and Minna Hirvasniemi and Kristiina Luopaj{\"a}rvi and Johansson, {Susanne Elise} and P{\"a}ivi Kleemola and Anna Parkkola and Hanna-Mari Pigg and Hilkka Puttonen and Martin Renlund and Kirsi Salonen and Heli Suomalainen and Kari Teramo and Anna-Liisa J{\"a}rvenp{\"a}{\"a} and Anu-Maaria H{\"a}m{\"a}l{\"a}inen",

year = "2018",

month = jan,

day = "2",

doi = "10.1001/jama.2017.19826",

language = "English",

volume = "319",

pages = "38--48",

journal = "JAMA : The Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "1",

}

TRIGR Study Group, Hyytinen, M , Knip, M, Åkerblom, HK, Al Taji, E, Becker, D, Bruining, J, Castano, L, Danne, T, de Beaufort, C, Dosch, H-M, Dupre, J, Fraser, WD, Howard, N, Ilonen, J, Konrad, D, Kordonouri, O, Krischer, JP, Lawson, ML, Ludvigsson, J, Madacsy, L, Mahon, JL, Ormisson, A, Palmer, JP, Pozzilli, P, Savilahti, E, Serrano-Rios, M, Songini, M, Taback, S, Vaarala, O, White, NH, Virtanen, SM, Wasikowa, R, Heikkilä, M, Hirvasniemi, M, Luopajärvi, K, Johansson, SE, Kleemola, P, Parkkola, A, Pigg, H-M, Puttonen, H, Renlund, M, Salonen, K, Suomalainen, H, Teramo, K , Järvenpää, A-L & Hämäläinen, A-M 2018, 'Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes The TRIGR Randomized Clinical Trial', JAMA : The Journal of the American Medical Association, Vuosikerta 319, Nro 1, Sivut 38-48. https://doi.org/10.1001/jama.2017.19826, https://doi.org/10.1001/jama.2017.19826

Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes The TRIGR Randomized Clinical Trial. / TRIGR Study Group ; Hyytinen, Mila ; Knip, Mikael et al.
julkaisussa: JAMA : The Journal of the American Medical Association, Vuosikerta 319, Nro 1, 02.01.2018, s. 38-48.

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

TY - JOUR

T1 - Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes The TRIGR Randomized Clinical Trial

AU - TRIGR Study Group

AU - Hyytinen, Mila

AU - Knip, Mikael

AU - Åkerblom, Hans K.

AU - Al Taji, Eva

AU - Becker, Dorothy

AU - Bruining, Jan

AU - Castano, Luis

AU - Danne, Thomas

AU - de Beaufort, Carine

AU - Dosch, Hans-Michael

AU - Dupre, John

AU - Fraser, William D.

AU - Howard, Neville

AU - Ilonen, Jorma

AU - Konrad, Daniel

AU - Kordonouri, Olga

AU - Krischer, Jeffrey P.

AU - Lawson, Margaret L.

AU - Ludvigsson, Johnny

AU - Madacsy, Laszlo

AU - Mahon, Jeffrey L.

AU - Ormisson, Anne

AU - Palmer, Jerry P.

AU - Pozzilli, Paolo

AU - Savilahti, Erkki

AU - Serrano-Rios, Manuel

AU - Songini, Marco

AU - Taback, Shayne

AU - Vaarala, Outi

AU - White, Neil H.

AU - Virtanen, Suvi M.

AU - Wasikowa, Renata

AU - Heikkilä, Maija

AU - Hirvasniemi, Minna

AU - Luopajärvi, Kristiina

AU - Johansson, Susanne Elise

AU - Kleemola, Päivi

AU - Parkkola, Anna

AU - Pigg, Hanna-Mari

AU - Puttonen, Hilkka

AU - Renlund, Martin

AU - Salonen, Kirsi

AU - Suomalainen, Heli

AU - Teramo, Kari

AU - Järvenpää, Anna-Liisa

AU - Hämäläinen, Anu-Maaria

PY - 2018/1/2

Y1 - 2018/1/2

KW - BETA-CELL AUTOIMMUNITY

KW - ISLET AUTOIMMUNITY

KW - GENERAL-POPULATION

KW - CHILDREN

KW - CHILDHOOD

KW - AUTOANTIBODIES

KW - SUSCEPTIBILITY

KW - PROGRESSION

KW - MELLITUS

KW - INSULIN

KW - 3121 General medicine, internal medicine and other clinical medicine

U2 - 10.1001/jama.2017.19826

DO - 10.1001/jama.2017.19826

M3 - Article

SN - 0098-7484

VL - 319

SP - 38

EP - 48

JO - JAMA : The Journal of the American Medical Association

JF - JAMA : The Journal of the American Medical Association

IS - 1

ER -